Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of...

36

Transcript of Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of...

Page 1: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.
Page 2: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Evaluating & ManagingThe Dual Diagnosis Patient

Peter A. DeMaria, Jr.., M.D., FASAMCoordinator of Psychiatric Services

Tuttleman Counseling ServicesClinical Associate Professor of Psychiatry & Behavioral

SciencesDepartment of Psychiatry & Behavioral Sciences

Temple University School of MedicinePhiladelphia, Pennsylvania

Page 3: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study AAnne is a 19 year old student who tells you that

she has been diagnosed with ADHD, anorexia nervosa, depression, borderline personality disorder and alcoholism. She is prescribed methylphenidate (Concerta), citalopram (Celexa), quetiapine (Seroquel) and alprazolam (Xanax). She recently had a relationship break-up. She feels her depression is getting worse and she has started to drink again. She appears of average height and weight.

Page 4: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study BBrian is a 20 year old student who complains of

problems with concentration and focus. He finds that he forgets to do important things; this forgetfulness has caused problems with his schoolwork and in his relationship with his GF. He has a well documented ADHD history and would like to restart his stimulant. He reports that he likes to party with his friends on the weekends and smokes MJ during the week to help him relax and sleep.

Page 5: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study C

Bill is a 21 year old student who presents stating that he has mood swings and can’t sleep. He has a history of binge alcohol and cocaine use, but says he hasn’t had any cocaine in a month.

Page 6: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Presenting Psychiatric Symptoms

• Anxiety• Depression• Insomnia• Psychotic symptoms• Disruptive behavior

Page 7: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Causes of Psychiatric Symptoms

• Drug intoxication or withdrawal states• Medical illness• Psychiatric comorbidity

Page 8: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

The Challenge

MentalIllness

Substance UseDisorder

DualDiagnosis

Page 9: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Definition of Addictive DiseaseAddiction is a primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by continuous or episodic impaired control over drinking or drug use, preoccupation with alcohol or drugs, use of alcohol or drugs despite adverse consequences, and distortion in thinking, most notably denial.

(Adapted from the NCADD and ASAM Definition of Alcoholism.)

Page 10: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Chronic Disease Model• Prototypes: CAD, HTN, DM• Development and course reflect an

interplay of genetic vulnerability, pathophysiology, and personal behaviors

• Treatment focuses on management not cure

• Goals include highest quality of life• Patient must take an active role in

treatment• Compliance is frequently an issue

Page 11: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Substance Use Is a Spectrum Disorder

Abstinence

Experimentation Substance abuse

Substance dependence

Page 12: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Lifetime Prevalence of Comorbidity - ECA Date

Mental Disorders, 22.5% Comorbidity = 29%

•Alcohol = 22%•Other drug = 15%

Alcohol Disorder, 13.5% Comorbidity = 45%

•Psychiatric - 37%•Other drug = 22%

Other Drug Disorder = 6.1% Comorbidity = 72%

•Psychiatric = 53%•Alcohol = 47%JAMA 264(19):2511-2518,1990

Page 13: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Epidemiology of Dual Diagnosis

• ECA Study: Alcoholics have 1.5 - 2 x higher incidence of depression than general population

• Alcoholics:

– At intake 70% have moderate to severe depression

– 4 - 6 weeks after detox 10-20% had major depression

• Psychiatric inpatients at McLean Hospital: 60% of males and 40% of females met criteria for alcohol or drug abuse or dependence

Page 14: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Epidemiology of Dual Diagnosis

• Cocaine addicts at McLean Hospital: 27% had affective illness.

• Opiate addicts: 54% had lifetime incidence and 24% had current episode of major depression.

• 15.2% of respondents in the NCS who had ADHD met criteria for any substance use disorder (3 x the rate of respondents without ADHD).

Page 15: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

The Biopsychosocial Spiritual Orientation

Biological

Psychological Social

Spiritual

Page 16: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

The Biopsychosocial Spiritual Orientation

• Biological– Genetics– Health issues– Brain chemistry

• Social– Living unit– Relationships– Work/school– Cultural factors

• Spiritual– Organizing principles– Morals/ethics– Cultural factors

• Psychological– Self esteem– Identity– Object relations– Drives/defenses/ conflicts– Developmental history– Trauma/abuse– Personality traits– Relationships

Page 17: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Dual Diagnosis

“Dual diagnosis is an expectation, not an exception.”

-Dr. Kenneth Minkoff

www.kenminkoff.com

Page 18: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

The Four Quadrant Model for Co-Occurring Disorders

Both High Severity Mental Illness Low SeveritySubstance Use Disorder High Severity

Mental Illness High SeveritySubstance Use Disorder Low Severity

Both Low Severity

A guide to treatment planning.

Page 19: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Disorder Parallels

Addiction Major Mental Illness

A biological illness A biological illness

Heredity (in part) Heredity (in part)

Chronic disease Chronic diseaseIncurable Incurable

Leads to lack of control of behavior and emotions

Leads to lack of control of behavior and emotions

Positive & negative symptoms

Positive & negative symptoms

Page 20: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Disorder Parallels

Addiction Major Mental Illness

Affects the whole family Affects the whole family

Progression of the disease without treatment

Progression of the disease without treatment

Symptoms can be controlled with proper treatment

Symptoms can be controlled with proper treatment

Disease of denial Disease of denial

Facing the disease can lead to depression & despair

Facing the disease can lead to depression & despair

Page 21: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Disorder Parallels

Addiction Major Mental Illness

Disease is often seen as a “moral issue” due to personal weakness rather than having biological causes

Disease is often seen as a “moral issue” due to personal weakness rather than having biological causes

Feelings of guilt and failure Feelings of guilt and failure

Feelings of shame and stigma

Feelings of shame and stigma

Physical, mental, & spiritual disease

Physical, mental, & spiritual disease

Page 22: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Screening-Assessment-Treatment

• High index of suspicion

• Screen everyone; revisit regularly

• Assess which Stage of Change

• Engage in treatment

• Use Motivational Interviewing techniques

• Use behavioral/contingency contacts

• Involve others

• Consult/Refer

Page 23: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Precontemplation

Contemplation

Preparation

Action

Maintenance

Stages of Change

Page 24: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Differentiating Substance Related Disorders from Psychiatric Disorders

• Relationship of symptoms to drug use• Which came first?• Presence of symptoms during periods of sobriety• Past treatment history• Atypical presentation• Poor or unpredictable response to treatment• Family history-psychiatric or addiction• Look for common co-morbidities:

– Bipolar disorder and alcoholism– ADHD and substance abuse– Cluster B personality traits/disorder

Page 25: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

General Approach to the Dual Diagnosis Patient

• Comprehensive biopsychosocial spiritual assessment.

• Engage patient in treatment and develop a therapeutic relationship.

• Develop a treatment plan– Addressing both psychiatric & addiction issues

• Assess response• Adjust treatment plan

Page 26: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Treatment Planning• Treatment planning must be individualized.• The treatment plan must follow a careful

assessment.• The treatment plan is not static, it is dynamic

and changes as the providers learns more and the patient changes with interventions.

• Develop a treatment team utilizing the expertise in other clinicians.

• Ensure regular and thorough communication between all treatment team members.

Page 27: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Possible Treatment Modalities• Individual counseling/therapy (psychiatric/addiction)• Group counseling/therapy (psychiatric/addiction)• Self-help (12 step) programs• Behavioral/contingency management• Couple’s Therapy• Family therapy• Disability Resources & Services Involvement• IOP/Partial hospitalization• Inpatient psychiatric (dual diagnosis) hospitalization• Psychotropic medication (psychiatric/addiction)

Page 28: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Issues Specific to College MH Practice

• Hospitalization necessary/indicated?

• Treat in-house or refer out?

• Is drug screening available?

• Must the student be clean for everything?

• If not, what is acceptable?

• What support is available on campus?

Page 29: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Pharmacotherapy of Addictive Disorders

• Detoxification• Aversive agents

– Disulfiram (Antabuse)

• Anti-craving Agents– Naltrexone (ReVia, Vivitrol)– Acamprosate (Campral)– Bupropion (Wellbutrin, Zyban)– Varenicline (Chantix)

Page 30: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Pharmacotherapy of Addictive Disorders

• Maintenance pharmacotherapy– Nicotine replacement therapy (NRT)

• Patch, gum, inhaler, lozenge

– Opioid maintenance pharmacotherapy• Methadone• Buprenorphine (Subutex/Suboxone)

Page 31: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

General Approach to Psychopharmacology

• Use biopsychosocial spiritual model• Avoid addictive substances (e.g. BZ)• Treat psychiatric condition if it prevents

engagement in addiction treatment.• Avoid making psychiatric diagnosis and

initiating medication until 2-4 weeks into abstinence from substances.

• Less is better

Page 32: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.
Page 33: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study AAnne is a 19 year old student who tells you that

she has been diagnosed with ADHD, anorexia nervosa, depression, borderline personality disorder and alcoholism. She is prescribed methylphenidate (Concerta), citalopram (Celexa), quetiapine (Seroquel) and alprazolam (Xanax). She recently had a relationship break-up. She feels her depression is getting worse and she has started to drink again. She appears of average height and weight.

Page 34: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study BBrian is a 20 year old student who complains of

problems with concentration and focus. He finds that he forgets to do important things; this forgetfulness has caused problems with his schoolwork and in his relationship with his GF. He has a well documented ADHD history and would like to restart his stimulant. He reports that he likes to party with his friends on the weekends and smokes MJ during the week to help him relax and sleep.

Page 35: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.

Case Study C

Bill is a 21 year old student who presents stating that he has mood swings and can’t sleep. He has a history of binge alcohol and cocaine use, but says he hasn’t had any cocaine in a month.

Page 36: Evaluating & Managing The Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services.